Home › Gilead beats back Roche, wins U.K. victory for hepatitis C drug Sovaldi
 

Keywords :   


Gilead beats back Roche, wins U.K. victory for hepatitis C drug Sovaldi

2014-08-16 09:15:14| Biotech - Topix.net

An arbitration panel ruled Friday that the Foster City-based drug maker's hepatitis C blockbuster Sovaldi did not infringe a 2004 research deal that rival Roche had with Pharmasset Inc. Gilead , led by Chairman and CEO John Martin , bought Pharmasset in 2012 for $11 billion, landing the drug that would become Sovaldi.

Tags: back drug victory wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Weekly Recap: PPG, Axalta, AkzoNobel Top This Weeks Stories
21.09Atlantic Tropical Weather Outlook
More »